|
Showing 1 - 3 of
3 matches in All Departments
This concise handbook provides oncologists and other healthcare
providers with crucial updates in the field, including an updated
review of the current understanding of the biology of the HER2
pathway, an overview of HER2-testing, and evidence-based
discussions of available and emerging HER2-targeted treatment
options. An essential clinical text for physicians that screen and
treat patients with breast cancer and require an accessible,
up-to-date survey of the dynamic treatment landscape.
Breast cancer is the most frequently diagnosed cancer and the
leading cause of cancer death in women worldwide, accounting for
nearly a quarter of the total new cancer cases each year. Of these
cases, approximately 15-25% overexpress HER2, a transmembrane RTK
kinase that is associated with aggressive tumor growth and poor
outcomes. However, in the past decade, survival rates of patients
with HER-positive breast cancer have significantly improved due to
increased screening, HER2 testing, and breakthrough HER2-targeted
drug therapies. Handbook of HER2-Targeted Agents in Breast Cancer
provides oncologists, primary care physicians, trainees and other
healthcare providers with a concise, accessible, and up-to-date
survey of the field, including a review of our current
understanding of the biology of the HER2 pathway and the rationale
for targeting it in early-stage and advanced breast cancer, an
overview of HER2-testing, and evidence-based discussions of
available HER2-targeted regimens in the adjuvant and metastatic
settings.
|
You may like...
Oop Sirkel
De Waal Venter
Paperback
R10
R8
Discovery Miles 80
|